AOD-9604 | Peptide Encyclopedia | Auryx
AOD-9604 is a physician-reviewed Auryx Learn encyclopedia entry. A modified fragment (hGH 176–191) of human growth hormone that triggers fat burning without affecting blood glucose or IGF-1 levels. This page is educational. It is not a dosing guide and not a substitute for a licensed clinician.
How it works
AOD-9604 contains the lipolytic sequence of hGH — the C-terminal end responsible for fat-burning signaling — without the metabolic side effects of full HGH. It activates β3 adrenergic receptors to stimulate lipolysis in adipose tissue, particularly visceral and subcutaneous fat, while having no impact on cell proliferation or insulin resistance.
- Targeted fat oxidation without glucose disruption
- No IGF-1 elevation — safe for longer-term protocols
- Supports visceral fat reduction
- Well-tolerated with a favorable safety profile
Ideal for individuals focused on targeted fat reduction who want to avoid the metabolic effects of full GH or GLP-1 protocols.
Subject of multiple research studies examining the lipolytic properties of the C-terminal fragment of human growth hormone. Received GRAS (Generally Recognized As Safe) status in the US for food applications.
Clinic context and next steps
Pair this entry with the matching shop listing when Auryx offers the compound, or browse the full encyclopedia. Category shopping lives under shop. Mechanism language is not a personal outcome and does not approve a protocol.
Auryx is an MD-led telemedicine clinic. Eligible patients complete remote intake; compounds ship from regulated United States compounding pharmacies after clinical review. Use the protocol finder if you are matching a goal, our method for the four-step process, and about for physician leadership. Citations sit on sources. Questions go to contact or info@auryxlife.com.
Nothing on Learn diagnoses, treats, cures, or prevents disease. Read privacy and terms before you share health information. Language homepages: español and português.